| Nome do produto |
monoxerutin |
| Nome em inglês |
monoxerutin;Monoxerutin [INN]; 2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-(2-hydroxyethoxy)-4-oxo-4H-chromen-3-yl-(6-O-(6-desoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosid); 3,3',4',5-Tetrahydroxy-7-(2-hydroxyethoxy)flavon-3-(6-O-(6-desoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosid); 3,3',4',5-Tetrahydroxy-7-(2-hydroxyethoxy)flavone 3-(6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside); BRN 4777354; Mono-7-hydroxyethylrutoside; Monoxerutina; Monoxerutina [INN-Spanish]; Monoxerutine; Monoxerutine [INN-French]; Monoxerutinum; Monoxerutinum [INN-Latin]; O-(beta-Hydroxyethyl)rutin; O-(beta-Hydroxyethyl)rutoside; Paroven; Relvene; Rutilemone; UNII-EKF7043SBU; Varemoid; Venoruton; Z 12007; ZYMA SA; beta-Hydroxyethylrutosid; Flavone, 3,3',4',5-tetrahydroxy-7-(2-hydroxyethoxy)-, 3-(6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside); Monoxerutin; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-(2-hydroxyethoxy)-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-L-mannopyranosyl)-D-glucopyranoside; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-(2-hydroxyethoxy)-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside |
| Fórmula molecular |
C29H34O17 |
| Peso Molecular |
654.5701 |
| InChI |
InChI=1/C29H34O17/c1-10-19(34)22(37)24(39)28(43-10)42-9-17-20(35)23(38)25(40)29(45-17)46-27-21(36)18-15(33)7-12(41-5-4-30)8-16(18)44-26(27)11-2-3-13(31)14(32)6-11/h2-3,6-8,10,17,19-20,22-25,28-35,37-40H,4-5,9H2,1H3/t10-,17+,19-,20+,22+,23-,24+,25+,28+,29-/m0/s1 |
| CAS Registry Number |
23869-24-1 |
| EINECS |
245-917-9 |
| Estrutura Molecular |
|
| Densidade |
1.759g/cm3 |
| Ponto de ebulição |
1022.548°C at 760 mmHg |
| índice de refração |
1.734 |
| O ponto de inflamação |
332.089°C |
| Pressão de vapor |
0mmHg at 25°C |
| Símbolos de perigo |
|
| Códigos de risco |
|
| Descrição da Segurança |
|
|
